Covance Inc. (NYSE: CVD) today announced the further extension of its LabLinkSM on-line access tool for central laboratory test data. LabLink now provides clients with access to information pertaining to the management of test specimens and the status of time-sensitive kits supplied to investigator sites. In addition, users now have increased autonomy and flexibility to create and schedule reports on the status of their clinical trial laboratory tests. The new capabilities in LabLink were added as the result of an extensive interview process with over 500 LabLink users and are a direct response to the needs communicated by those and other LabLink users. The enhancements have been operational since September 2005.
